Contact this trialFirst, we need to learn more about you.
Glucagon-like peptide-1 receptor agonist
Semaglutide for Weight Management in Obesity
Recruiting3 awardsPhase 4
Loma Linda, California
This trial will see if semaglutide is better than existing anti-obesity meds in weight loss and quality of life, from a diverse group of participants from 3 US employers.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.